Dairy Products Increase Risk of Prostate Cancer
Dairy products can increase the risk of prostate cancer, according to a new study published in the Journal of Nutrition. Researchers tracked data from 21,660 participants in the Physicians Heath Study for 28 years. Those who consumed more than 2.5 servings of dairy products per day were at a 12 percent increased risk of prostate cancer, compared with those who consumed less than half a serving (one serving equals an 8-ounce glass of milk or 2 ounces of cheese). For skim milk, men were at increased risk for early stage prostate cancer. For whole milk, men drinking more than 1 glass per day had double the risk for fatal prostate cancer, compared with men drinking less. The authors concluded that this study further adds to the connection between dairy intake and prostate cancer.
Previous studies have shown similar relationships between dairy products and prostate cancer.
Song Y, Chavarro JE, Cao Y, et al. Whole milk intake is associated with prostate cancer-specific mortality among U.S. male physicians. J Nutr. 2013;143(2):189-196.
Chan JM, Stampfer MJ, Ma J, Gann PH, Gaziano JM, Giovannucci E. Dairy products, calcium, and prostate cancer risk in the Physicians’ Health Study. Am J Clin Nutr. 2001;74(4):549-554.
For information about nutrition and health, please visit www.pcrm.org/.
Breaking Medical News is a service of the Physicians Committee for Responsible Medicine,
5100 Wisconsin Avenue, N.W., Suite 400, Washington, DC 20016.
(Send your news to email@example.com, Foodconsumer.org is part of the Infoplus.com ™ news and information network)
- Fresh Frozen™ Vegetables Recalled
- Prominent Government Watchdog Asks Obama Administration to Remove Organic Leadership at USDA
- Hospira Issues A Voluntary Nationwide Recall Of One Lot Of Bupivacaine HCl Injection Due To Potential Iron Oxide Particulate In Glass Vials
- Organic Watchdog Grows Scientific Staff, Leadership Capacity The Cornucopia Institute Adds Staff, Announces Board Election Results
- Elevated cholesterol and triglycerides may increase the risk for prostate cancer recurrence